Steno-sphere: Navigating the enigmatic world of emerging multidrug-resistant Stenotrophomonas maltophilia

Ashlan J Kunz Coyne1, Shelbye Herbin2, Kaylee Caniff1

  • 1Anti-Infective Research Laboratory, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.

Pharmacotherapy
|May 18, 2023
PubMed

Insights

Stenotrophomonas maltophilia infections are challenging due to limited treatment options and complex resistance. This review examines current and emerging strategies for managing these serious nosocomial infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Stenotrophomonas maltophilia is a significant opportunistic pathogen causing nosocomial infections, particularly in immunocompromised individuals.
  • High rates of antibiotic resistance, especially to carbapenems, complicate treatment, necessitating a review of therapeutic strategies.
  • Limited clinical data on first-line agents and emerging therapies hinder optimal patient management.

Purpose of the Study:

  • To review the epidemiology, resistance mechanisms, and diagnostic approaches for Stenotrophomonas maltophilia infections.
  • To evaluate current and emerging antimicrobial therapies, including PK/PD data and novel agents.
  • To provide a comprehensive overview for optimizing the management of S. maltophilia infections.

Main Methods:

  • Literature review of epidemiology, resistance, diagnostics, and therapeutics for S. maltophilia.
  • Analysis of clinical comparison data for first-line antibiotics (TMP-SMX, quinolones, minocycline).
  • Assessment of newer agents (cefiderocol, aztreonam-avibactam) and bacteriophage therapy.

Main Results:

  • Conflicting observational data exist for first-line agents, with no clear preferred monotherapy or combination.
  • Emerging antibiotics like cefiderocol and aztreonam-avibactam show promise for drug-resistant strains, but require more outcome data.
  • Bacteriophage therapy for S. maltophilia infections is largely unexplored, with limited in-vitro and in-vivo evidence.

Conclusions:

  • Effective management of S. maltophilia infections requires understanding its complex resistance and virulence.
  • Further clinical outcome data are crucial for guiding the use of novel antimicrobial agents.
  • Comprehensive strategies integrating diagnostics, PK/PD, and emerging therapies are needed to combat these challenging infections.

Related Concept Videos

Special Staining Techniques01:13

Special Staining Techniques

Specialized staining techniques play a vital role in microbiology by enabling the visualization of specific bacterial structures that remain undetectable with standard microscopy methods. These techniques not only enhance the structural visualization of bacterial cells but also provide critical insights into their pathogenicity and classification. Additionally, they support diagnostic and research endeavors in microbiology by identifying key bacterial features.Capsule Staining for Virulence...
Deep Sea Microbial Ecology01:18

Deep Sea Microbial Ecology

The deep ocean and its underlying sediments represent vast, largely unexplored microbial habitats that extend far beyond the sunlit photic zone. The photic (euphotic) zone typically spans the upper ~100–200 meters of pelagic waters in the open ocean, but its depth varies geographically and seasonally, where sufficient light supports photosynthetic life. Below this lies the deep sea, spanning roughly 1000–6000 meters (bathypelagic to abyssal zones), with deeper hadal trenches extending beyond...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...